Gainers
-
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares rose 42.9 percent to $5.00 in pre-market trading after the
company disclosed that its Phase 3 study evaluating amphora for hormone-free birth control met primary endpoint.
-
Proteostasis Therapeutics, Inc. (NASDAQ: PTI) rose 21 percent to $5.82 in pre-market trading after reporting a global
license agreement with Genentech.
-
SandRidge Permian Trust (NYSE: PER) rose
20.9 percent to $2.49 in pre-market trading.
-
Axovant Sciences Ltd. (NASDAQ: AXON)
rose 17.8 percent to $1.19 in pre-market trading after Jefferies upgraded the stock from hold to buy and raised its price
target from $2.50 to $3 per share.
-
Ability Inc. (NASDAQ: ABIL) rose 12.1
percent to $2.51 in pre-market trading.
-
Barnes & Noble, Inc. (NYSE: BKS) rose 8.6
percent to $7.05 in pre-market trading.
-
Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) rose 8.1 percent to $2.29 in pre-market trading. Foresight and RH
Electronics signed a non-binding development and investment agreement.
-
PPDAI Group Inc. (NYSE: PPDF) rose 7.1
percent to $4.70 in pre-market trading after dropping 10.77 percent on Friday.
-
Gridsum Holding Inc. (NASDAQ: GSUM)
shares rose 6.6 percent to $4.22 in pre-market trading.
-
Fluent, Inc. (NASDAQ: FLNT) rose 5.8
percent to $4.00 in pre-market trading.
-
Caladrius Biosciences, Inc. (NASDAQ: CLBS) rose 5.5 percent to $5.00 in pre-market trading.
-
Capital Southwest Corporation (NASDAQ: CSWC) rose 5 percent to $21.08 in pre-market trading.
-
Embraer SA (NYSE: ERJ) rose 3.4 percent
to $21.84 in pre-market trading after announcing Boeing would acquire 80% of the company for $4.2 billion.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and
losers
Losers
-
Alliqua BioMedical, Inc. (NASDAQ: ALQA) fell 10.1 percent to $2.42 in pre-market trading after climbing 26.29
percent on Friday.
-
Best Buy Co., Inc. (NYSE: BBY) fell 6.1
percent to $52.03 in pre-market trading after Bank of America downgraded the stock from neutral to underperform and lowered its
price target from $70 to $50 per share.
-
360 Finance, Inc. (NASDAQ: QFIN) fell
6.1 percent to $15.50 in pre-market trading.
-
Tenet Healthcare Corporation (NYSE: THC)
fell 5.7 percent to $20.02 in pre-market trading after dropping 9.39 percent on Friday.
-
Beazer Homes USA, Inc. (NYSE: BZH) fell
5.3 percent to $10.00 in pre-market trading.
-
Centene Corporation (NYSE: CNC) fell 3.7
percent to $122.77 in pre-market trading after declining 4.02 percent on Friday.
-
Uxin Limited (NASDAQ: UXIN) shares
fell 3.1 percent to $7.27 in pre-market trading after rising 4.75 percent on Friday.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.